Novo Nordisk's new indications for semaglutide and its attractive pipeline could allow it to bounce back. Intuitive Surgical should remain the leader in its niche despite increased competition. Both ...

Medtronic earned regulatory clearance in the U.S. for its Hugo robotic-assisted surgery system. This device will take time to have a material impact on the company's financial results. Still, ...

Medtronic is a solid choice for dividend investors, but Intuitive Surgical is a better option for growth-oriented investors. Intuitive Surgical will continue dominating its niche even as Medtronic ...